Founded in 1985, focusing on the research and development of children's calcium supplementation products, the national production base of pediatric medicine of Chinese patent medicine, Longmu Zhuanggu granules are well-known in the industry
Longmu Zhuanggu Granules is a well-known brand under Wuhan Jianmin Group with a glorious history of nearly 20 years and has created a miracle of long-lasting prosperity in China's pharmaceutical industry, which has nurtured the healthy growth of two generations of Chinese children.
The main medicinal materials of Longmu Zhuang Bone Granules (such as Poria cocos, Mai Dong, etc.) are directly selected from the raw materials of the GAP medicinal material planting base specially built by Wuhan Jianmin Group, and the medicinal materials are natural and authentic. There are strict quality control standards for each link and process in the production process, so that "unqualified raw materials do not enter the factory, unqualified semi-finished products do not transfer to the next process, and unqualified products do not leave the factory".
The advent and best-selling of "Longmu" has created amazing market performance and brand value, and also made Wuhan Jianmin, a young enterprise with a long history, full of vitality, and has since been well-known inside and outside the Great Wall, north and south of the river.
"Dragon Mu" once led the coquettish market of children's calcium supplement products. Now, it has been challenged by strong competition from other similar competitors, and is facing a grim situation where its market share is constantly eroded and carved up. It has nurtured the growth of two whole generations in China.
In 1985, he was born in Wuhan Children's Hospital, which filled the gap in the prevention and treatment of pediatric rickets with traditional Chinese medicine as the main body in China.
In 1990, it was included in the Hubei Provincial Drug Standard;
In 1992, it was listed as the only first-class protected variety of calcium supplementation in China;
In 1993, it was recommended by the China Child Protection Center as the best pediatric calcium supplement and calcium absorption drug;
In 1994, it was listed as the first Chinese patent medicine by the National Rickets Prevention and Control Collaboration Group;
In 1995, it was included in the drug standards of the Ministry of Health;
In 1999, it was listed as a national essential drug;
In 2000, it was included in the 2000 edition of the Chinese Pharmacopoeia;
In 2002, it was listed as a national prescription drug and over-the-counter drug (OTC) double-cross variety;
In the same year, it was included in "Pediatrics of Traditional Chinese Medicine" (the planning textbook of national higher Chinese medicine schools in the new century).
Wuhan JianminIt is one of the top 50 enterprises in China's pharmaceutical industry, and Group Co., Ltd. is a national key high-tech enterprise, a national pediatric production base of proprietary Chinese medicine, and a national key traditional Chinese medicine enterprise. The predecessor of the group is Ye Kaitai Pharmacy, one of the four oldest Chinese medicine stores in China, which has a history of nearly four centuries and now has more than ten subsidiaries, integrating production, scientific research, economy and trade, with an annual production capacity of nearly one billion yuan.
Since the reform and opening up, the group company has taken the revitalization of national medicine as its own responsibility, actively promoted the reform of the enterprise, continuously explored the new management system and operation mechanism, vigorously improved the innovation ability of the enterprise, promoted the comprehensive development of the company, and the enterprise has obtained better social and economic benefits than ever before, created a miracle of the steady operation of state-owned enterprises, and ranked among the top 500 enterprises and the top 50 in the industry in terms of comprehensive strength. In recent years, the Group has vigorously implemented the strategy of developing the industry through science and technology, established a company that adheres to the R&D, production and sales of traditional Chinese medicine as its main business, focuses on the development of pediatric drugs, geriatric drugs and drugs for major and difficult diseases urgently needed by the market, and builds a technology-leading pharmaceutical group based on the modernization and industrialization of traditional Chinese medicine and supported by high-tech drugs.
At present, Jianmin Group has successfully researched and developed a series of products represented by Longmu Zhuanggu Granules, Jianmin Throat Tablets, Spleen and Blood Granules, Bentong Capsules, and Slow Liver Ning Capsules, forming a spectacular "famous brand forest" of the group, and the products are sold all over the country and exported to Southeast Asia, Europe and the United States and regions. In recent years, the group has successively won the titles of "National Advanced Enterprise of Quality and Efficiency", "National Excellent Enterprise in the Traditional Chinese Medicine Industry", "National May Day Labor Award" and other titles, and is known as "a banner for invigorating state-owned enterprises", and the trademark of "Jianmin" has also won the title of "well-known protection". A Jianmin Group based on the traditional Chinese medicine industry and characterized by high and new technology will surely create more brilliant achievements in the new century and compose a beautiful movement for the revitalization of Chinese medicine.
